Join to View Full Profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Fax+1 773-834-7374
Dr. Rampurwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2012 - 2015
University of ConnecticutResidency, Internal Medicine, 2009 - 2012
Government Medical College GujuratClass of 2007
Certifications & Licensure
IL State Medical License 2016 - 2026
WI State Medical License 2012 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.Nan Chen, Margarite Matossian, Poornima Saha, Murtuza Rampurwala, Salaija Kamaraju
Breast Cancer Research and Treatment. 2025-05-01 - SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J Wilkinson, Emily M Whitman-Purves
Clinical Cancer Research. 2024-12-16 - 2 citationsFinal analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant.Benjamin A Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, David E Avigan, Murtuza Rampurwala
Blood Cancer Journal. 2024-05-29
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
